Moderate Persistent Asthma Treated with Combined Budesonide-Formoterol Inhaler: A Case Report

Asthma is a chronic respiratory disease with increasing prevalence around the world.Asthma can affect the patient's quality of life in the long term, therefore therapy for asthma is very important. Patient?s compliance is very crucial in asthma therapy. Combined Budesonide plus Formoterolin a single inhaler is an asthma therapy that may be used for both maintenance and reliever. This case report presents a case of 34-year-old male which was diagnosed with moderate persistent asthma and wasmanaged with inhaled budesonide plus formoterol. There was an increase of Asthma Control Test from 11 into 24 after one month therapy and there was no exacerbation. Unfortunately, the patient was not adhere to the treatment because he was already feeling healthy. There was no improvement from the spirometry test, possibly because short follow-up or lack of patient?s compliance. Single inhaler is easier and more applicable to the patient compared to budesonide and formoterol via separate inhaler. This study showed that Combined Budesonide - Formoterol inhaler could be used as a therapy for moderate persistent asthma, but patient compliance is very important to determine the success of the therapy.